DNA adducts, mutant frequencies, and mutation spectra in various organs of lambda lacZ mice exposed to ethylating agents
Related Experiment Video
Updated: Oct 30, 2026

The Lambda Select cII Mutation Detection System
Published on: April 26, 2018
E J Mientjes1, A Luiten-Schuite, E van der Wolf
1Department of Molecular Toxicology, TNO Nutrition and Food Research Institute, Zeist, The Netherlands.
Abstract:
To investigate tissue-specific relations between DNA adducts and mutagenesis in vivo, lambda lacZ transgenic mice were treated i.p. with N-ethyl-N-nitrosourea (ENU), diethylnitrosamine (DEN), and ethyl methanesulphonate (EMS). In liver, bone marrow, and brain DNA from mice sacrificed at several time points after treatment O6-ethylguanine (O6-EtG) and N7-ethylguanine (N7-EtG) levels were determined as well as the mutant frequency (MF) in lacZ. In liver DNA of ENU- and DEN-treated mice, the bulk of O6-EtG was removed at 3 days after treatment, while the MF continued to increase thereafter. This suggests that O6-EtG is not the major premutagenic lesion in the liver. Indeed, sequence analysis of mutants showed only 24% GC-->AT transitions, consistent with the O6-EtG lesion, and 28% TA-->AT transversions, expected from O2-ethylthymine. In bone marrow after ENU treatment, a maximum mutation induction occurred at 3 days post-treatment, of which 43% were GC-->AT mutations and 22% were TA-->AT mutations. This suggests that in bone marrow O6-EtG may be a major premutagenic lesion at the 3-day time point. In liver and bone marrow, EMS treatment gave rise to a high level of N7-EtG and a low level of O6-EtG but no increase in MF. No adducts or mutation induction were observed in bone marrow of DEN-treated mice. No MF increase was observed in the brain of either ENU- or EMS-treated mice, although O6- and N7-adducts were present.
Insights
This study examined DNA adducts and mutations in mouse tissues after exposure to N-ethyl-N-nitrosourea (ENU), diethylnitrosamine (DEN), and ethyl methanesulphonate (EMS). O6-ethylguanine (O6-EtG) was not the primary mutagenic lesion in liver, but may be in bone marrow.
Area of Science:
- Toxicology
- Molecular Biology
- Genetics
Background:
- DNA adducts are chemical modifications to DNA that can lead to mutations.
- Understanding the relationship between specific DNA adducts and mutagenesis is crucial for assessing chemical toxicity.
- Tissue-specific differences in DNA repair and mutagenesis can influence toxicological outcomes.
Purpose of the Study:
- To investigate the tissue-specific relationship between DNA adduct formation and mutagenesis in vivo.
- To determine if O6-ethylguanine (O6-EtG) is a major premutagenic lesion in different mouse tissues after exposure to ethylating agents.
- To compare the mutagenic potential of N-ethyl-N-nitrosourea (ENU), diethylnitrosamine (DEN), and ethyl methanesulphonate (EMS) in liver, bone marrow, and brain.
Main Methods:
- Lambda lacZ transgenic mice were treated with ENU, DEN, and EMS.
- DNA adduct levels (O6-EtG, N7-EtG) and mutant frequency (MF) in the lacZ gene were measured in liver, bone marrow, and brain at various time points.
- Mutant DNA sequences were analyzed to identify mutation types.
Main Results:
- In mouse liver, O6-EtG was rapidly removed, and mutant frequency continued to rise, suggesting O6-EtG is not the main premutagenic lesion.
- Sequence analysis revealed GC-->AT transitions and TA-->AT transversions in liver mutants, with the latter possibly arising from O2-ethylthymine.
- In bone marrow after ENU treatment, O6-EtG may be a major premutagenic lesion at 3 days, correlating with mutation induction and GC-->AT mutations.
- EMS treatment resulted in high N7-EtG but low O6-EtG and no increased MF in liver and bone marrow.
- No adducts or mutations were detected in bone marrow after DEN treatment or in the brain after ENU or EMS treatment.
Conclusions:
- The role of O6-EtG as a premutagenic lesion is tissue-specific, being potentially significant in bone marrow but not in liver.
- Other DNA adducts, such as O2-ethylthymine, may contribute to mutagenesis.
- The brain appears resistant to the mutagenic effects of these ethylating agents, despite adduct formation.
Related Concept Videos
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Spontaneous and Induced Mutations

